Gentium names CEO, closes NY office

Following it's license agreement with Sigma-Tau, Gentium said it will be closing its New York office and consolidating corporate activities and the executive management team within its headquarters in Italy. CFO Gary Gemignani will be leaving the company at the end of the month, and Dr. Khalid Islam, currently Gentium's Chairman and Interim CEO, will become the full-time CEO. Gentium release

Suggested Articles

Outgoing BIO Chair John Maraganore and his successor, Jeremy Levin, reflected on drug pricing, its drivers and its place in the innovation ecosystem.

The study is assessing the effect of the oral AXL inhibitor when given to elderly AML patients in combination with low-intensity chemotherapy.

The proportion of patients who had a greater than 1 g/dL increase in hemoglobin is down on GBT’s prior update but still superior to placebo.